Literature DB >> 12817079

Helix 1/8 interactions influence the activity of nuclear receptor ligand-binding domains.

Jason A Holt1, Thomas G Consler, Shawn P Williams, Andrea H Ayscue, Lisa M Leesnitzer, G Bruce Wisely, Andrew N Billin.   

Abstract

The ligand-binding domain (LBD) of apo-nuclear receptors in solution is thought to be a very dynamic structure with many possible conformations. Upon ligand binding, the structure is stabilized to a more rigid conformation. The dynamic stabilization assay is a LBD reassembly assay that takes advantage of the high specificity of the intramolecular interactions that comprise the ligand-bound LBD. Here, we demonstrate dynamic stabilization for the nuclear receptors peroxisome proliferator-activated receptor (PPAR)gamma and nerve growth factor inducible (NGFIB)beta and identify residues important for stabilization of the intramolecular interactions induced by PPARgamma ligands. Site-directed mutagenesis studies identified residues in helices 1 and 8 required for LBD reassembly. Further, disrupting the helix 1/8 interaction in the context of the holo-LBD alters the response of the receptor in a compound-specific manner, suggesting that residues far from the ligand-binding pocket can influence the stability of the ligand-bound receptor. Thus, these results support and extend models of the apo-LBD of PPARgamma as a dynamic structure.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12817079     DOI: 10.1210/me.2003-0001

Source DB:  PubMed          Journal:  Mol Endocrinol        ISSN: 0888-8809


  5 in total

1.  The Ras inhibitors caveolin-1 and docking protein 1 activate peroxisome proliferator-activated receptor γ through spatial relocalization at helix 7 of its ligand-binding domain.

Authors:  Elke Burgermeister; Teresa Friedrich; Ivana Hitkova; Ivonne Regel; Henrik Einwächter; Wolfgang Zimmermann; Christoph Röcken; Aurel Perren; Matthew B Wright; Roland M Schmid; Rony Seger; Matthias P A Ebert
Journal:  Mol Cell Biol       Date:  2011-06-20       Impact factor: 4.272

2.  Molecular evolution of the switch for progesterone and spironolactone from mineralocorticoid receptor agonist to antagonist.

Authors:  Peter J Fuller; Yi-Zhou Yao; Ruitao Jin; Sitong He; Beatriz Martín-Fernández; Morag J Young; Brian J Smith
Journal:  Proc Natl Acad Sci U S A       Date:  2019-08-22       Impact factor: 11.205

3.  ERRgamma regulates cardiac, gastric, and renal potassium homeostasis.

Authors:  William A Alaynick; James M Way; Stephanie A Wilson; William G Benson; Liming Pei; Michael Downes; Ruth Yu; Johan W Jonker; Jason A Holt; Deepak K Rajpal; Hao Li; Joan Stuart; Ruth McPherson; Katja S Remlinger; Ching-Yi Chang; Donald P McDonnell; Ronald M Evans; Andrew N Billin
Journal:  Mol Endocrinol       Date:  2009-12-04

4.  Unique functional properties of a member of the Fushi Tarazu-Factor 1 family from Schistosoma mansoni.

Authors:  Benjamin Bertin; Souphatta Sasorith; Stéphanie Caby; Frédérik Oger; Jocelyne Cornette; Jean-Marie Wurtz; Raymond J Pierce
Journal:  Biochem J       Date:  2004-08-15       Impact factor: 3.857

5.  Mutations of ESRRB encoding estrogen-related receptor beta cause autosomal-recessive nonsyndromic hearing impairment DFNB35.

Authors:  Rob W J Collin; Ersan Kalay; Muhammad Tariq; Theo Peters; Bert van der Zwaag; Hanka Venselaar; Jaap Oostrik; Kwanghyuk Lee; Zubair M Ahmed; Refik Caylan; Yun Li; Henk A Spierenburg; Erol Eyupoglu; Angelien Heister; Saima Riazuddin; Elif Bahat; Muhammad Ansar; Selcuk Arslan; Bernd Wollnik; Han G Brunner; Cor W R J Cremers; Ahmet Karaguzel; Wasim Ahmad; Frans P M Cremers; Gert Vriend; Thomas B Friedman; Sheikh Riazuddin; Suzanne M Leal; Hannie Kremer
Journal:  Am J Hum Genet       Date:  2008-01       Impact factor: 11.025

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.